{{Rsnum
|rsid=987107
|Gene=IL7R
|Chromosome=5
|position=35875125
|Orientation=minus
|GMAF=0.2163
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IL7R
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.9 | 42.5 | 10.6
| HCB | 89.8 | 10.2 | 0.0
| JPT | 90.3 | 8.8 | 0.9
| YRI | 42.2 | 42.2 | 15.6
| ASW | 52.6 | 43.9 | 3.5
| CHB | 89.8 | 10.2 | 0.0
| CHD | 90.8 | 9.2 | 0.0
| GIH | 65.3 | 29.7 | 5.0
| LWK | 64.5 | 29.1 | 6.4
| MEX | 69.0 | 31.0 | 0.0
| MKK | 67.9 | 28.8 | 3.2
| TSI | 51.0 | 38.2 | 10.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs987107
|Name_s=
|Gene_s=IL7R
|Feature=
|Evidence=PubMed ID:17660816
|Annotation=In a case-control study of Nordic populations, rs987107 was associated with risk of multiple sclerosis.
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Curated
|PharmGKB Accession ID=PA162356126
}}

{{PharmGKB
|RSID=rs987107
|Name_s=
|Gene_s=IL7R
|Feature=
|Evidence=PubMed ID:17660816
|Annotation=In a nordic case-control group consisted of 1,820 individuals with multiple sclerosis and 2,634 healthy controls this SNP in intron 6 of the IL7R gene confirmed association with multiple sclerosis.
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Curated
|PharmGKB Accession ID=PA162355786
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs987107
|overall_frequency_n=33
|overall_frequency_d=128
|overall_frequency=0.257812
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=26
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}